X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://investors.vigilneuro.com/news-releases/news-release-details/vigil-neuroscience-receives-positive-opinion-european-medicines
https://investors.vigilneuro.com/news-releases/news-release-details/vigil-neuroscience-presents-vgl101-complete-phase-1-data-and
https://investors.vigilneuro.com/news-releases/news-release-details/vigil-neuroscience-announces-update-its-small-molecule-trem2
https://investors.vigilneuro.com/news-releases/news-release-details/vigil-neuroscience-present-2023-morgan-stanley-global-healthcare
https://endpts.com/fda-lifts-partial-clinical-hold-on-vigil-neurosciences-trem2-antibody-removing-dosing-cap/
https://www.clinicaltrialsarena.com/news/vigil-phase-ii-alsp-therapy/
https://investors.vigilneuro.com/news-releases/news-release-details/vigil-neuroscience-strengthens-board-directors-appointment
https://endpts.com/vigil-neuroscience-hits-wall-street-with-two-ex-amgen-trem2-agonists/
https://investors.vigilneuro.com/news-releases/news-release-details/vigil-neuroscience-announces-closing-initial-public-offering
https://www.biopharmadive.com/news/biotech-ipo-performance-investors-2021/616808/
Market Place
Share 
